| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |